UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 8 von 226
Datensatz exportieren als...
BibTeX
Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology
Journal of surgical oncology, 2015-02, Vol.111 (2), p.237-242
van Oudheusden, T.R.
Braam, H.J.
Nienhuijs, S.W.
Wiezer, M.J.
van Ramshorst, B.
Luyer, P.
de Hingh, I.H.
2015
Details
Autor(en) / Beteiligte
van Oudheusden, T.R.
Braam, H.J.
Nienhuijs, S.W.
Wiezer, M.J.
van Ramshorst, B.
Luyer, P.
de Hingh, I.H.
Titel
Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology
Ist Teil von
Journal of surgical oncology, 2015-02, Vol.111 (2), p.237-242
Ort / Verlag
United States: Blackwell Publishing Ltd
Erscheinungsjahr
2015
Link zum Volltext
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
Background Signet ring cell cancer (SRCC) patients have a poor oncologic outcome. The aim of this study was to determine whether the potential drawbacks of hyperthermic intraperitoneal chemotherapy (HIPEC) outweigh the benefits in patients with peritoneally metastasized SRCC. Methods Patients with peritoneal carcinomatosis (PC) of colorectal origin referred to two tertiary centers between April 2005 and December 2013 were identified and retrospectively analyzed. Data were compared between SRCC histology and other differentiations. Results Three‐hundred‐fifty‐one patients were referred for CRS + HIPEC among which 20 (5.7%) patients were identified with SRCC histology. CRS + HIPEC was performed in 16 of these 20 (80%) and 252 out of the 331 remaining patients (76.1%). A higher proportion of patients in the SRCC‐group were diagnosed with N2 stage (62.5% vs. 36.1%, P = 0.04). A macroscopic complete resection was achieved in 87.5% and 97.2% respectively (P = 0.04). Median survival was 14.1 months compared to 35.1 months (P < 0.01). Recurrence occurred in 68.8% of the SRCC patients and in 43.7% of the other histology patients (P = 0.05). Conclusion Patients with SRCC and PC treated with CRS + HIPEC have a poor median survival only slightly reaching over 1 year. In the presence of other relative contraindications, SRCC histology should refrain a surgeon from performing CRS and HIPEC. J. Surg. Oncol. 2015 111:237–242. © 2014 Wiley Periodicals, Inc.
Sprache
Englisch
Identifikatoren
ISSN: 0022-4790
eISSN: 1096-9098
DOI: 10.1002/jso.23784
Titel-ID: cdi_proquest_miscellaneous_1652403081
Format
–
Schlagworte
Adult
,
Aged
,
carcinoma
,
Carcinoma, Signet Ring Cell - mortality
,
Carcinoma, Signet Ring Cell - pathology
,
Carcinoma, Signet Ring Cell - secondary
,
Carcinoma, Signet Ring Cell - therapy
,
Chemotherapy, Cancer, Regional Perfusion
,
Colorectal Neoplasms - mortality
,
Colorectal Neoplasms - pathology
,
Combined Modality Therapy
,
Cytoreduction Surgical Procedures
,
cytoreductive surgery
,
Female
,
HIPEC
,
Humans
,
Hyperthermia, Induced
,
Male
,
Middle Aged
,
Neoplasm Recurrence, Local
,
peritoneal carcinomatosis
,
Peritoneal Neoplasms - mortality
,
Peritoneal Neoplasms - secondary
,
Peritoneal Neoplasms - therapy
,
Retrospective Studies
,
signet ring cell
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX